P2A Peptide: Mechanism of Action & Research Applications
Disclaimer: All content on this site is an educational summary of public academic and industry research, compiled for informational reference only. It is not medical or laboratory advice. No treatment, health, or purchasing decisions should be made based solely on website content. This site does not sell peptides, does not link sellers, and does not endorse any vendor or any use of any compound.
Definition and core facts
A p2a peptide is a short self-processing sequence — 18–22 residues from the 2A family of viral oligopeptides — that makes a ribosome finish one protein and start another without a stop codon. The name comes from the 2A region of viral genomes where these sequences were first characterized; porcine teschovirus-1 2A (P2A) is the laboratory standard, typically quoted as the sequence ATNFSLLKQAGDVEENPGP.
The mechanism is not proteolysis. The 2A sequence imposes a conformation on the ribosome's catalytic center such that the peptide bond between the final glycine and the proline is not formed: glycine arrives at the P site, release occurs with the upstream product ending in …Gly, and translation re-initiates at the proline, producing the downstream product beginning with Pro. The event is called ribosomal skipping or stop-carry-on, and the “cleavage” language that surrounds it in casual descriptions is strictly a misnomer.
Structure and mechanism
Structurally, 2A sequences share a conserved motif: a D(V/I)EXNPGP C-terminus with a helical upstream segment that pushes on the exit tunnel. The skipping efficiency varies by family (P2A is favored for its higher efficiency), by sequence context around the junction, and by expression system — and the residual proline on the downstream product is a permanent, documented modification that downstream experiments must account for.
Because the products are generated at a fixed stoichiometry from one mRNA, 2A sequences became the standard for co-expression: linking an antibody heavy and light chain, a reporter to a target, a CAR and its marker. The alternative — an IRES, which requires one mRNA but re-initiates with lower and variable second-cistron efficiency — loses the equal-stoichiometry property; two separate vectors lose the single-construct property. The trade is documented extensively in expression-vector literature.
How it is measured and used in research
Assay of the mechanism: the read-out is the ratio of upstream to downstream product (Western blot of separated products, or reporter ratios), and “skipping efficiency” is the fraction of ribosomes that skip rather than read through into a fusion product. Mutagenesis of the NPGP motif abolishes skipping and restores a single fusion protein — the classic control experiment.
The connection to the rest of this cluster is the peptide bond itself: 2A is the one sequence famous for preventing bond formation. Everything else on the site — the chain, the signal peptide that co-appears in secretory constructs — depends on bonds forming normally; 2A is the exception that proves how tightly formation is controlled.
Research context and related pages
For researchers using 2A vectors, the practical parameters: family choice (P2A preferred for efficiency), junction context (a flexible linker upstream can improve folding of both products), and accounting for the N-terminal proline on the downstream product in downstream assays. All three are documented in vector-design literature.
The mechanism's home topic is translational control; its practical home is the expression vector; its chemistry home is the peptide science pillar, which links it to the rest of the self-processing and chain-structure pages in this cluster.
How to use the data on this page
Step 1 — extract the parameters. Extract: the 2A family, exact sequence used, junction context, and measured skipping efficiency in the expression system used.
Step 2 — normalize before comparing. Normalize: compare skipping efficiencies only within the same system and assay; published numbers vary by construct and host.
Step 3 — grade the source. Grade: primary literature on 2A mechanisms Tier 1; vector-design reviews Tier 2; vendor vector maps Tier 3.
Parameter comparison
2A family properties relevant to the mechanism of action.
| Parameter | P2A value/behavior | Notes |
|---|---|---|
| Sequence (PTV-1) | ATNFSLLKQAGDVEENPGP | 20-residue standard |
| Skip site | Gly | Pro bond not formed | Products end Gly / begin Pro |
| Efficiency | High (~60-90%+ by context) | System- and junction-dependent |
| Stoichiometry | Fixed by single mRNA | Advantage vs IRES |
| Downstream modification | N-terminal Pro retained | Assay consideration |
Table: 2A family properties relevant to the mechanism of action. — compiled from public regulatory and academic sources; verify against the original documents before use.
Frequently asked questions
What does the 2A peptide actually do?
It makes the ribosome terminate the upstream protein and re-initiate at the proline codon without completing the glycine-proline peptide bond — a process called ribosomal skipping. No enzyme cuts anything; the bond simply never forms. The result is two separate protein products from one open reading frame at fixed stoichiometry, which is why 2A sequences are standard in co-expression vectors.
References
- de Felipe P et al. E, the stop codon: functional pseudoknot... 2A literature on ribosomal skipping (Traffic / J Virol, early 2000s).
- Donnelly MLL et al. Analysis of the aphthovirus 2A/2B polyprotein 'cleavage' mechanism indicates not a proteolytic reaction, but a novel translational effect. J Gen Virol, 2001.
- Szymczak-Workext AL et al. Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide-based retroviral vector. Nat Biotechnol, 2004.